[Value of monitoring serum carcinoembryonic antigen (CEA) levels for prognosis of patients with lung cancer treated by non-surgical methods].
D000230:Adenocarcinoma / Q000628:therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D018288:Carcinoma, Small Cell / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*; D008991:Monitoring, Physiologic; D011379:Prognosis; D011879:Radiotherapy Dosage
D000970:Antineoplastic Agents; D002272:Carcinoembryonic Antigen
Wartość monitorowania poziomów antygenu karcinoembryionalnego (CEA) w surowicy krwi dla oceny rokowania u chorych na raka płuca leczonych nieoperacyjnie.